Prostate cancer is the second most commonly diagnosed cancer in men globally, according to the World Health Organisation (WHO ...

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on ...

The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as ...

Amendment reduces and simplifies royalty structure on Teverelix® from ~4% to 2% while preserving global rights and IP control ...

Unlock the biological power of gingerol to ignite your metabolism, extinguish chronic inflammation, and transform your ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

What these buzzy new tests can and can't tell you.

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing ...

Alpha Tau Medical targets major 2026 catalysts as Alpha DaRT gains momentum; key pancreatic & GBM readouts ahead. Read the full analysis here of DRTS stock.

Global Radiopharmaceuticals Market Size The global Radiopharmaceuticals market revenue was USD 6761 Million in 2022 and is ...

Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...

To make things easier for Stidham, the Broncos need Sutton to have a big game, and Davis is a good matchup for Sutton. Davis was tied for the most penalized player in the NFL during the regular season ...